Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC

Abstract

Immunotherapy has revolutionized cancer treatment, dramatically improving survival rates of melanoma and lung cancer patients. Nevertheless, immunotherapy is almost ineffective against ovarian cancer (OC) due to its cold tumor immune microenvironment (TIM). Many traditional medications aimed at remodeling TIM are often associated with severe systemic toxicity, require frequent dosing, and show only modest clinical efficacy. In recent years, emerging nanomedicines have demonstrated extraordinary immunotherapeutic effects for OC by reversing the TIM because the physical and biochemical features of nanomedicines can all be harnessed to obtain optimal and expected tissue distribution and cellular uptake. However, nanomedicines are far from being widely explored in the field of OC immunotherapy due to the lack of appreciation for the professional barriers of nanomedicine and pathology, limiting the horizons of biomedical researchers and materials scientists. Herein, a typical cold tumor‐OC is adopted as a paradigm to introduce the classification of TIM, the TIM characteristics of OC, and the advantages of nanomedicines for immunotherapy. Subsequently, current nanomedicines are comprehensively summarized through five general strategies to substantially enhance the efficacy of immunotherapy by heating the cold OC. Finally, the challenges and perspectives of this expanding field for improved development of clinical applications are also discussed.

Ultra-small molybdenum-based nanodots as an antioxidant platform for effective treatment of periodontal disease

“…However, most conventional antioxidants are usually confined by the poor dispersity, low stability, and short duration of action. Meanwhile, natural enzymes and single-component nanozymes usually show a high specificity for a certain ROS and therefore, fail to scavenge various ROS generated during disease progression ( Goyal et al, 2014 ; Yang et al, 2022a ; Yang et al, 2022b ; Xiao et al, 2022 ). Furthermore, the synthesis of the multienzyme-based antioxidant is often complicated, shows low stability, and is difficult to be repeated.…”

Exploring prognostic indicators in the pathological images of ovarian cancer based on a deep survival network

“…Ovarian cancer with low tumor-infiltrating lymphocyte is considered “cold” tumor ( Yang et al, 2022 ). The results of our immune infiltration analysis also showed no difference in activated CD8 T-cells between the high and low risk score subgroups.…”

Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney

“…High levels of RONS disrupt vital cellular processes in many oxidative stress related diseases by attacking DNA due to their high reactivity [ 76 , 79 , 173 ]. Unfortunately, unlike tumor tissues which have developed efficient mechanisms of RONS detoxification (mainly involving enhancement of antioxidant abilities and upregulation of pro-survival and pro-repair molecules), normal tissues such as kidneys are difficult to cope with large-scale oxidative stress in time [ 174 , 175 ]. Correspondingly, the administration of exogenous accessible DNA can directly react with RONS to reduce cell damage and alleviate AKI.…”